Literature DB >> 19562762

Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication.

Joanne DiFrancisco-Donoghue1, Ahmed Elokda, Eric M Lamberg, Nancy Bono, William G Werner.   

Abstract

The aim of this experiment is to understand how Parkinson's disease (PD) medication affects the autonomic responses of individuals during an acute exercise stress test. Fourteen people with PD and fifteen healthy individuals age-matched between 50 and 80 years performed a modified Bruce protocol. Subjects with PD performed the test once off medication (PD-off) and then 1 week later on medication (PD-on). Heart rate (HR), blood pressure (BP), VO(2), and norepinephrine (NE) levels were taken at rest and at peak exercise. At peak exercise HR, BP, and NE values for the PD-on and PD-off group were all significantly lower than healthy controls, regardless of whether subjects were on their medication. Autonomic abnormalities during exercise in this population appear to be disease manifested and not impacted by medications used to treat PD. We can assume, both on and off medication, this population will show markedly lower BP, HR, and NE responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562762     DOI: 10.1002/mds.22612

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.

Authors:  Lucy Norcliffe-Kaufmann; Horacio Kaufmann; Jose-Alberto Palma; Cyndya A Shibao; Italo Biaggioni; Amanda C Peltier; Wolfgang Singer; Phillip A Low; David S Goldstein; Christopher H Gibbons; Roy Freeman; David Robertson
Journal:  Ann Neurol       Date:  2018-03-10       Impact factor: 10.422

2.  The Effect of Parkinson Drug Timing on Cardiovascular Response during Treadmill Exercise in a Person with Parkinson Disease and Freezing of Gait.

Authors:  Cheryl M Petersen; Reid Nelson; Teresa M Steffen
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

3.  Effects of exercise induced oxidative stress on glutathione levels in Parkinson's disease on and off medication.

Authors:  Ahmed Elokda; Joanne DiFrancisco-Donoghue; Eric M Lamberg; William G Werner
Journal:  J Neurol       Date:  2010-05-12       Impact factor: 4.849

4.  The Submaximal Clinical Exercise Tolerance Test (SXTT) to Establish Safe Exercise Prescription Parameters for Patients with Chronic Disease and Disability.

Authors:  Eduard Gappmaier
Journal:  Cardiopulm Phys Ther J       Date:  2012-06

Review 5.  Autonomic disorders predicting Parkinson's disease.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

6.  Effects of Tyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Joanne DiFrancisco-Donoghue; Ely Rabin; Eric M Lamberg; William G Werner
Journal:  Mov Disord Clin Pract       Date:  2014-10-23

7.  Enhanced Exercise Therapy in Parkinson's disease: A comparative effectiveness trial.

Authors:  Angela L Ridgel; Benjamin L Walter; Curtis Tatsuoka; Ellen M Walter; Kari Colón-Zimmermann; Elisabeth Welter; Martha Sajatovic
Journal:  J Sci Med Sport       Date:  2015-02-07       Impact factor: 4.319

8.  The reliability and minimal detectable change of the cardiovascular response and self-selected exercise intensity during forward and backward treadmill exercise in individuals with Parkinson disease.

Authors:  Reid Nelson; Cheryl Petersen
Journal:  SAGE Open Med       Date:  2017-10-16

9.  Guidelines on exercise testing and prescription for patients at different stages of Parkinson's disease.

Authors:  Camilla Martignon; Anna Pedrinolla; Federico Ruzzante; Gaia Giuriato; Fabio Giuseppe Laginestra; Raquel Bouça-Machado; Joaquim J Ferreira; Michele Tinazzi; Federico Schena; Massimo Venturelli
Journal:  Aging Clin Exp Res       Date:  2020-06-08       Impact factor: 3.636

10.  Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.

Authors:  Eva Stuebner; Ekawat Vichayanrat; David A Low; Christopher J Mathias; Stefan Isenmann; Carl-Albrecht Haensch
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.